COVID-19 as a Trigger of Brain Autoimmunity

Area of Science:

• Neuroscience
• Immunology
• Virology

Background:

• Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can invade the central nervous system (CNS).
• CNS invasion by SARS-CoV-2 activates microglia, leading to chronic neuroinflammation.
• This neuroinflammation is linked to potential neurodegeneration and autoimmune responses.

Purpose of the Study:

• To explore the mechanisms by which SARS-CoV-2 infection may initiate a CNS autoimmune cascade.
• To understand the molecular similarities between SARS-CoV-2 and human CNS proteins.
• To elucidate the role of neuroinflammation and autoantibodies in COVID-19-related neurological conditions.

Main Methods:

• Analysis of the SARS-CoV-2 transcriptome.
• Comparison of viral molecular features with human CNS protein epitopes.
• Review of pathways involved in autoimmune responses within the CNS.

Main Results:

• The SARS-CoV-2 transcriptome shares molecular similarities with human CNS protein epitopes.
• These similarities can trigger a cytokine storm and autoantibody production.
• Multiple pathways, including molecular mimicry and epitope spreading, contribute to CNS autoimmunity.

Conclusions:

• COVID-19 can initiate a central nervous system autoimmune cascade.
• Chronic neuroinflammation and autoantibody generation are key consequences of SARS-CoV-2 CNS entry.
• Understanding these mechanisms is crucial for addressing neurological complications of COVID-19.